AI Article Synopsis

  • BIA-ALCL is a rare type of lymphoma linked primarily to textured breast implants, typically showing up years later as a fluid buildup near the implant.
  • Estimates indicate that the incidence might be as high as one in 3300 for patients with specific textured implants by Allergan, with 688 total reported cases worldwide as of February 2019.
  • A new case is presented of a woman who developed BIA-ALCL after transitioning from textured tissue expanders to smooth round implants, highlighting the potential risk associated even with smooth implants following textured ones.

Article Abstract

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a malignancy associated with textured breast implants. BIA-ALCL is typically restricted to the periprosthetic capsule, presenting as a unilateral recurrent seroma years after placement of a textured breast implant. Current estimates suggest an incidence of one in 3300 for patients with Allergan Biocell textured implants. As of February 6, 2019, U.S. Medical Device Reporting associated with BIA-ALCL showed 457 unique cases of BIA-ALCL, with 24 "unverified and potentially inaccurate" cases associated with a nontextured implant. As of February of 2019, there were 688 reported cases to date worldwide. To date, there are no published case reports of BIA-ALCL associated exclusively with smooth implants or with smooth implants after textured expanders, and there has been no reported smooth-only case in any registry, database, or journal worldwide. The authors present a case of BIA-ALCL associated with smooth round implants and textured tissue expanders. A 56-year-old woman was treated for left stage IIA invasive ductal carcinoma with bilateral mastectomies and immediate reconstruction with bilateral subpectoral textured tissue expanders. She underwent exchange to Mentor smooth-round implants, and completed adjuvant chemotherapy. Magnetic resonance imaging and examination 4.5 years after implant placement showed no abnormal findings. The patient had left breast trauma 5 years following implant placement while taking adalimumab, and developed an open wound requiring explantation. A recurrent seroma developed, and tested positive for BIA-ALCL on cytology. Surgical pathologic examination after total capsulectomy demonstrated stage IA BIA-ALCL. To the authors' knowledge, this is the first case report of BIA-ALCL in a patient with textured expanders followed by prolonged exposure to smooth round implants.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000008155DOI Listing

Publication Analysis

Top Keywords

bia-alcl associated
12
smooth round
12
bia-alcl
10
case bia-alcl
8
breast implant
8
textured breast
8
recurrent seroma
8
february 2019
8
smooth implants
8
implants textured
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!